AVEO Pharmaceuticals (AVEO) Reports In-Line Q1 Loss of 77c/Share

Article Stock Quotes (1) Comments (0)

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q1 EPS of ($0.77), in-line with the analyst estimate of ($0.77). Revenue for the quarter came in at $860 thousand versus the consensus estimate of $1.99 million.

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
• UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
• Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?